EVIDENCE OF A SELECTIVE DEPLETION OF A CD16(+) CD56(+) CD8(+) NATURAL-KILLER-CELL SUBSET DURING HIV-INFECTION

被引:63
作者
LUCIA, B
JENNINGS, C
CAUDA, R
ORTONA, L
LANDAY, AL
机构
[1] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT IMMUNOL MICROBIOL, CHICAGO, IL 60612 USA
[2] UNIV CATTOLICA SACRO CUORE, INST CLIN MALATTIE INFETT, I-00168 ROME, ITALY
来源
CYTOMETRY | 1995年 / 22卷 / 01期
关键词
NK; HIV DISEASE; FLOW CYTOMETRY;
D O I
10.1002/cyto.990220103
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Three-color flow cytometric analysis of CD16+ natural killer (NK) cells was assessed in HIV seropositive patients and healthy heterosexual controls. A selective depletion of lymphocytes with the CD16+ NK phenotype was found among the HIV+ infected patients. When the CD16 lymphocyte subset was further evaluated by three-color flow cytometry, cells bearing both the CD8 and CD56 antigens were significantly decreased. Analysis of activation antigens revealed a large proportion of CD16(+) NK cells from HIV+ patients expressed HLA-DR, but this did not correlate with CD25 (IL-2 receptor) expression, The overall loss of the CD8 and CD56 antigens among the NK population with an increase in activation status may be due to differential loss of the NK cell subsets or, alternatively, to the loss of immunoregulatory cytokines, which have been shown to be important in maintaining NK activity. Whether these changes in the NK compartment may influence the outcome of individuals with HIV disease still remains an open question but is an important issue when performing phenotypic analysis of HIV+ subjects. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:10 / 15
页数:6
相关论文
共 44 条
  • [1] ALCOCERVARELA J, 1985, CLIN EXP IMMUNOL, V60, P31
  • [2] BONAVIDA B, 1986, J IMMUNOL, V137, P1157
  • [3] DIFFERENTIAL SURFACE MARKER EXPRESSION IN PATIENTS WITH CD-16+ LYMPHOPROLIFERATIVE DISORDERS - INVIVO MODEL FOR NK DIFFERENTIATION
    BRAY, RA
    GOTTSCHALK, LR
    LANDAY, AL
    GEBEL, HM
    [J]. HUMAN IMMUNOLOGY, 1987, 19 (02) : 105 - 115
  • [4] NATURAL-KILLER CELL-FUNCTION IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME AND RELATED DISEASES
    BRENNER, BG
    DASCAL, A
    MARGOLESE, RG
    WAINBERG, MA
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1989, 46 (01) : 75 - 83
  • [5] CAI Q, 1990, J ACQ IMMUN DEF SYND, V3, P669
  • [6] INHIBITION OF NORMAL HUMAN NATURAL-KILLER CELL-ACTIVITY BY HUMAN IMMUNODEFICIENCY VIRUS SYNTHETIC TRANSMEMBRANE PEPTIDES
    CAUDA, R
    TUMBARELLO, M
    ORTONA, L
    KANDA, P
    KENNEDY, RC
    CHANH, TC
    [J]. CELLULAR IMMUNOLOGY, 1988, 115 (01) : 57 - 65
  • [7] INVITRO INFECTION OF NATURAL-KILLER-CELLS WITH DIFFERENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
    CHEHIMI, J
    BANDYOPADHYAY, S
    PRAKASH, K
    PERUSSIA, B
    HASSAN, NF
    KAWASHIMA, H
    CAMPBELL, D
    KORNBLUTH, J
    STARR, SE
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (04) : 1812 - 1822
  • [8] IMPAIRED INTERLEUKIN-12 PRODUCTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    CHEHIMI, J
    STARR, SE
    FRANK, I
    DANDREA, A
    MA, XJ
    MACGREGOR, RR
    SENNELIER, J
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) : 1361 - 1366
  • [9] EVIDENCE OF A NATURAL-KILLER (NK) CELL REPERTOIRE FOR (ALLO) ANTIGEN RECOGNITION - DEFINITION OF 5 DISTINCT NK-DETERMINED ALLOSPECIFICITIES IN HUMANS
    CICCONE, E
    PENDE, D
    VIALE, O
    DIDONATO, C
    TRIPODI, G
    ORENGO, AM
    GUARDIOLA, J
    MORETTA, A
    MORETTA, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) : 709 - 718
  • [10] PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    DANDREA, A
    RENGARAJU, M
    VALIANTE, NM
    CHEHIMI, J
    KUBIN, M
    ASTE, M
    CHAN, SH
    KOBAYASHI, M
    YOUNG, D
    NICKBARG, E
    CHIZZONITE, R
    WOLF, SF
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1387 - 1398